Reata Saves Millions Leveraging the Adaptive Functionality of Medidata Rave RTSM
Traditional approaches for randomization and trial supply management (RTSM) can include interfaces with multiple systems, each with its own separate data repository causing burdensome delays and increased costs.
Learn how Reata Pharmaceuticals created a positive patient experience while supporting a highly adaptive trial design and detailed protocol, efficiently and cost effectively. When assessing your RTSM approach ask yourself:
- Can your RTSM solution allow for a quick study setup and adapt to in-study modifications without downtime?
- Will your RTSM strategy help reduce risk and ensure data quality?
- Are you confident your RTSM solution gets the right treatment to the right patient, at the right time?
- Does your RTSM solution provide robust reporting capabilities enabling study teams to make quicker, informed decisions?
See how Reata adopted an RTSM strategy that reduced trial cost and risk while saving time. Download the case study today.